The CEO of a B.C. biotechnology company says the treatment his firm has developed for COVID-19 is sitting on shelves while people continue to die, despite it being approved for use by Health Canada in the fall.
B.C. biotech company says, despite interim approval, provinces won’t use its COVID-19 treatment
